Table 2.

Cost-effectiveness of various screening programs in the United States.

Condition, intervention	Patient age,years	Cost-effectiveness ratio,US$ per QALY gained	Reference
HIV infection
Testing of inpatients at presentation	Any	38,600	[16]
Testing of high-risk outpatients every 5 years	Any	50,000	[18]
Breast cancer, mammography every year	50–69	57,500	[22]
Colon cancer, FOBT and sigmoidoscopy every 5 years	50–85	57,700	[23]
Diabetes mellitus type 2, one-time opportunistic screening of fasting plasma glucose level	> 25	70,000	[24]

NOTE. FOBT, fecal occult blood test; QALY, quality-adjusted life-year.